Literature DB >> 28992164

Functional disability and other health-related quality-of-life domains: points to consider for clinical trials in systemic sclerosis.

Dinesh Khanna1, Ron D Hays2, Daniel E Furst3.   

Abstract

Patients with SSc have the highest mortality among the rheumatic diseases. In addition, SSc is associated with disfigurement, hand contractures, fatigue, poor sleep, severe RP with numbness and tingling of the fingers can lead to decrements in quality of life. This Points to Consider article provides practical considerations for design of trials for functional disability and other health-related quality-of-life issues.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  clinical trials; function; quality of life; scleroderma

Mesh：

Year:  2017        PMID： 28992164      PMCID： PMC5850118          DOI： 10.1093/rheumatology/kex193

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


  41 in total

1.  Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis.

Authors:  Dinesh Khanna; Daniel E Furst; Weng Kee Wong; Joel Tsevat; Philip J Clements; Grace S Park; Arnold E Postlethwaite; Mansoor Ahmed; Shaari Ginsburg; Ron D Hays
Journal:  Qual Life Res       Date:  2007-04-03       Impact factor: 4.147

2.  Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument.

Authors:  A Silman; A Akesson; J Newman; H Henriksson; G Sandquist; M Nihill; S Palfrey; R Lomas; F Wollheim; C Black
Journal:  J Rheumatol       Date:  1998-01       Impact factor: 4.666

3.  Pain, fatigue and hand function closely correlated to work ability and employment status in systemic sclerosis.

Authors:  Gunnel Sandqvist; Agneta Scheja; Roger Hesselstrand
Journal:  Rheumatology (Oxford)       Date:  2010-05-28       Impact factor: 7.580

4.  A cross-sectional comparison of three self-reported functional indices in scleroderma.

Authors:  A E Smyth; A J MacGregor; D Mukerjee; G M Brough; C M Black; C P Denton
Journal:  Rheumatology (Oxford)       Date:  2003-04-16       Impact factor: 7.580

5.  Sensitivity to change in systemic sclerosis of the McMaster-Toronto Arthritis Patient Preference Disability Questionnaire (MACTAR): shift in patient priorities over time.

Authors:  Christelle Nguyen; Luc Mouthon; Caroline Mestre-Stanislas; Francois Rannou; Alice Bérezné; Katherine Sanchez; Agathe Papelard; Michel Revel; Loïc Guillevin; Serge Poiraudeau
Journal:  J Rheumatol       Date:  2010-01-15       Impact factor: 4.666

Review 6.  Health-related quality of life--an introduction.

Authors:  Dinesh Khanna; Joel Tsevat
Journal:  Am J Manag Care       Date:  2007-12       Impact factor: 2.229

7.  Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.

Authors:  Dinesh Khanna; Xiaohong Yan; Donald P Tashkin; Daniel E Furst; Robert Elashoff; Michael D Roth; Richard Silver; Charlie Strange; Marcy Bolster; James R Seibold; David J Riley; Vivien M Hsu; John Varga; Dean E Schraufnagel; Arthur Theodore; Robert Simms; Robert Wise; Fredrick Wigley; Barbara White; Virginia Steen; Charles Read; Maureen Mayes; Ed Parsley; Kamal Mubarak; M Kari Connolly; Jeffrey Golden; Mitchell Olman; Barri Fessler; Naomi Rothfield; Mark Metersky; Philip J Clements
Journal:  Arthritis Rheum       Date:  2007-05

Review 8.  Measuring quality of life: 1995 update.

Authors:  D F Cella; A E Bonomi
Journal:  Oncology (Williston Park)       Date:  1995-11       Impact factor: 2.990

9.  Quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule II.

Authors:  Marie Hudson; Russell Steele; Suzanne Taillefer; Murray Baron
Journal:  Arthritis Rheum       Date:  2008-02-15

10.  Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II.

Authors:  Marie Hudson; Brett D Thombs; Russell Steele; Rita Watterson; Suzanne Taillefer; Murray Baron
Journal:  Arthritis Rheum       Date:  2008-02-15
View more
  7 in total

1.  Room for improvement in non-pharmacological systemic sclerosis care? - a cross-sectional online survey of 650 patients.

Authors:  Juliane K Stöcker; Madelon C Vonk; Frank H J van den Hoogen; Maria W G Nijhuis-van der Sanden; Julia Spierings; J Bart Staal; Ton Satink; Cornelia H M van den Ende
Journal:  BMC Rheumatol       Date:  2020-07-31

2.  Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study.

Authors:  Susan L Murphy; Mary Whitehouse Barber; Kate Homer; Carole Dodge; Gary R Cutter; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-11       Impact factor: 4.794

3.  Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II.

Authors:  Elizabeth R Volkmann; Donald P Tashkin; Holly LeClair; Michael D Roth; Grace Kim; Jonathan Goldin; Philip J Clements; Daniel E Furst; Dinesh Khanna
Journal:  ACR Open Rheumatol       Date:  2020-05-20

4.  Systemic sclerosis: state of the art on clinical practice guidelines.

Authors:  Vanessa Smith; Carlo Alberto Scirè; Rosaria Talarico; Paolo Airo; Tobias Alexander; Yannick Allanore; Cosimo Bruni; Veronica Codullo; Virgil Dalm; Jeska De Vries-Bouwstra; Alessandra Della Rossa; Oliver Distler; Ilaria Galetti; David Launay; Gemma Lepri; Alexis Mathian; Luc Mouthon; Barbara Ruaro; Alberto Sulli; Angela Tincani; Els Vandecasteele; Amber Vanhaecke; Marie Vanthuyne; Frank Van den Hoogen; Ronald Van Vollenhoven; Alexandre E Voskuyl; Elisabetta Zanatta; Stefano Bombardieri; Gerd Burmester; Fonseca João Eurico; Charissa Frank; Eric Hachulla; Frederic Houssiau; Ulf Mueller-Ladner; Matthias Schneider; Jacob M van Laar; Ana Vieira; Maurizio Cutolo; Marta Mosca; Marco Matucci-Cerinic
Journal:  RMD Open       Date:  2018-10-18

5.  A patient-centered approach to the burden of symptoms in patients with scleroderma treated with Bosentan: A prospective single-center observational study.

Authors:  Elena Rezus; Alexandra Maria Burlui; Bogdan Gafton; Teodora Alexa Stratulat; Gabriela Rusu Zota; Anca Cardoneanu; Ciprian Rezus
Journal:  Exp Ther Med       Date:  2019-12-20       Impact factor: 2.447

6.  Microangiopathy in Inflammatory Diseases-Strategies in Surgery of the Lower Extremity.

Authors:  Christoph Biehl; Lotta Biehl; Ingo Helmut Tarner; Ulf Müller-Ladner; Christian Heiss; Martin Heinrich
Journal:  Life (Basel)       Date:  2022-01-28

7.  Patient perception of disease burden in diffuse cutaneous systemic sclerosis.

Authors:  Dinesh Khanna; Yannick Allanore; Christopher P Denton; Marco Matucci-Cerinic; Janet Pope; Barbara Hinzmann; Siobhan Davies; Janethe de Oliveira Pena; Oliver Distler
Journal:  J Scleroderma Relat Disord       Date:  2019-08-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.